Methonocarbacycloalkylanaloga von Nucleosiden
EP1252160
Art B1
16. August 2006
Anmelder: The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP1252160
- Aktenzeichen
- EP01903043
- Anmeldetag
- 12. Januar 2001
- Veröffentlichung
- 16. August 2006
- Erteilung
- 16. August 2006
- Rechtsraum
- EP
- IPC
- C07D471/04C07D487/04C07D239/54C07D239/56C07D239/58A61P29/00A61P35/00A61K31/505A61K31/52// (C07D487/04239:00)C07D235:00
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES - Land
- 🇺🇸 USA
🇺🇸
Government of the United States of America As Represented By the Secretary of the Department of Health and Human Services
Der Anmelder ist die US-Regierung, vertreten durch das Gesundheitsministerium, unter dessen Dach unter anderem die National Institutes of Health forschen. Das Patentportfolio konzentriert sich auf Medizintechnik, Pharma- und Biotechnologie sowie auf organische Chemie und Messtechnik. Anmeldungen stammen aus dem Zeitraum 2000 bis 2016.
441 Patente in unserer Datenbank